Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management.
Marianne ZoghbiMohammad Jad MoussaJim DagherElio HarounAiham Z QdaisatEmad D SingerYara E KaramSai-Ching Jim YeungPatrick S ChaftariPublished in: Cancers (2024)
Brain metastases (BMs) are the most prevalent type of cerebral tumor, significantly affecting survival. In adults, lung cancer, breast cancer, and melanoma are the primary cancers associated with BMs. Symptoms often result from brain compression, and patients may present to the emergency department (ED) with life-threatening conditions. The goal of treatment of BMs is to maximize survival and quality of life by choosing the least toxic therapy. Surgical resection followed by cavity radiation or definitive stereotactic radiosurgery remains the standard approach, depending on the patient's condition. Conversely, whole brain radiation therapy is becoming more limited to cases with multiple inoperable BMs and is less frequently used for postoperative control. BMs often signal advanced systemic disease, and patients usually present to the ED with poorly controlled symptoms, justifying hospitalization. Over half of patients with BMs in the ED are admitted, making effective ED-based management a challenge. This article reviews the epidemiology, clinical manifestations, and current treatment options of patients with BMs. Additionally, it provides an overview of ED management and highlights the challenges faced in this setting. An improved understanding of the reasons for potentially avoidable hospitalizations in cancer patients with BMs is needed and could help emergency physicians distinguish patients who can be safely discharged from those who require observation or hospitalization.
Keyphrases
- emergency department
- end stage renal disease
- radiation therapy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- small cell lung cancer
- primary care
- brain metastases
- peritoneal dialysis
- risk factors
- prognostic factors
- squamous cell carcinoma
- cerebral ischemia
- free survival
- patient reported outcomes
- physical activity
- sleep quality
- mesenchymal stem cells
- blood brain barrier
- depressive symptoms